Skip to content
6-K

Foreign Interim / Material

Legend Biotech Corp LEGN

0001801198-25-000031

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q3 2025 · Sep 30, 2025 369.27M sh
Shares Diluted Q3 2025 · Sep 30, 2025 368.36M sh
Shares Diluted Q3 2025 · Sep 30, 2024 366.56M sh
Shares Diluted Q3 2025 · Sep 30, 2024 365.27M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$88M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$61.96M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $278.89M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $286.75M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $459.28M
Cash And Equivalents Q3 2025 · Dec 31, 2023 $1.28B
Stockholders Equity Q3 2025 · Sep 30, 2025 $1.01B
Stockholders Equity Q3 2025 · Dec 31, 2024 $1.04B
Stockholders Equity Q3 2025 · Sep 30, 2024 $1.12B
Stockholders Equity Q3 2025 · Dec 31, 2023 $1.25B
Current Liabilities Q3 2025 · Sep 30, 2025 $433.57M
Current Liabilities Q3 2025 · Dec 31, 2024 $277.65M
Total Liabilities Q3 2025 · Sep 30, 2025 $701.69M
Total Liabilities Q3 2025 · Dec 31, 2024 $629.61M
Current Assets Q3 2025 · Sep 30, 2025 $1.24B
Current Assets Q3 2025 · Dec 31, 2024 $1.28B
Total Assets Q3 2025 · Sep 30, 2025 $1.71B
Total Assets Q3 2025 · Dec 31, 2024 $1.67B
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.11
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.72
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.34
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.56
Eps Basic Q3 2025 · Sep 30, 2025 −$0.11
Eps Basic Q3 2025 · Sep 30, 2025 −$0.72
Eps Basic Q3 2025 · Sep 30, 2024 −$0.34
Eps Basic Q3 2025 · Sep 30, 2024 −$0.56
Rd Expense Q3 2025 · Sep 30, 2025 $113.15M
Rd Expense Q3 2025 · Sep 30, 2025 $313.37M
Rd Expense Q3 2025 · Sep 30, 2024 $95.52M
Rd Expense Q3 2025 · Sep 30, 2024 $309.11M
Net Income Q3 2025 · Sep 30, 2025 −$39.69M
Net Income Q3 2025 · Sep 30, 2025 −$265.99M
Net Income Q3 2025 · Sep 30, 2024 −$125.32M
Net Income Q3 2025 · Sep 30, 2024 −$203.31M
Operating Income Q3 2025 · Sep 30, 2025 −$43.45M
Operating Income Q3 2025 · Sep 30, 2025 −$116.87M
Operating Income Q3 2025 · Sep 30, 2024 −$70.36M
Operating Income Q3 2025 · Sep 30, 2024 −$230.19M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $113.26M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $277.63M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $52.51M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $146.97M
Revenue Q3 2025 · Sep 30, 2025 $272.33M
Revenue Q3 2025 · Sep 30, 2025 $722.52M
Revenue Q3 2025 · Sep 30, 2024 $160.21M
Revenue Q3 2025 · Sep 30, 2024 $440.72M